A Phase I/II Study of Stereotactic Hypofractionated Once-weekly Radiation Therapy (SHORT) for Prostate Cancer

Stereotactic radiation therapy has been investigated predominantly in patients with low –intermediate-risk disease. We conducted a clinical trial of stereotactic hypofractionated radiation therapy delivered in once-weekly fractions on patients with all-risk non-metastatic disease to test feasibility, acute toxicities and patient-reported outcomes.

Source: Clinical Oncology - September 20, 2019 Category: Radiology Authors: I. Mallick, M. Arunsingh, S. Chakraborty, B. Arun, S. Prasath, P. Roy, D. Dabkara, R. Achari, S. Chatterjee, S. Gupta Tags: Original Article Source Type: research